Imatinib Mesylate Effectiveness in Chronic Myeloid Leukemia with Additional Cytogenetic Abnormalities at Diagnosis among Black Africans
Imatinib mesylate provides good results in the treatment of CML in general. But what about the results of this treatment in CML associated with additional cytogenetic abnormalities at diagnosis among black Africans? For this, we retrospectively studied 27 cases of CML associated with additional cyto...
Saved in:
Main Authors: | Tolo Diebkilé Aïssata, Duni Sawadogo, Clotaire Nanho, Boidy Kouakou, N'dogomo Meité, N'Dhatz Emeuraude, Ayémou Roméo, Sekongo Yassongui Mamadou, Paul Kouéhion, Konan Mozart, Gustave Koffi, Ibrahima Sanogo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2013/901589 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation
by: Monika Conchon, et al.
Published: (2009-01-01) -
Influence of the Clinical Status on Stress Reticulocytes, CD 36 and CD 49d of SSFA2 Homozygous Sickle Cell Patients Followed in Abidjan
by: Duni Sawadogo, et al.
Published: (2014-01-01) -
Effectiveness rehabilitative therapy and Pridinol Mesylate in low back pain
by: Lorenza Lauricella, et al.
Published: (2025-01-01) -
Miliary Tuberculosis in Immunocompromised Patient Induced by Imatinib and Steroid
by: Randa Fermada, et al.
Published: (2022-01-01) -
Synthesis and evaluation of bisulfate/mesylate-conjugated chlortetracycline with high solubility and bioavailability
by: Liu Deng, et al.
Published: (2020-12-01)